Labshake search
Citations for Stemcell Technologies :
801 - 850 of 1294 citations for 4 1 1 2 3 3 3 Hexafluoropropoxy acetophenone since 2020
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Developmental Biology 2023Quote: ... Our hiPSC lines were cultivated under sterile conditions in mTeSR-1 (Stem Cell Technologies, Vancouver), changed daily ...
-
bioRxiv - Synthetic Biology 2024Quote: ... CD34+ HSPCs were cultured at 1-5×105 cells/mL in StemSpan SFEMII (STEMCELL Technologies) or Good Manufacturing Practice Stem Cell Growth Medium (SCGM ...
-
bioRxiv - Developmental Biology 2024Quote: ... hPSCs are dissociated on Day -1 using either Accutase or Dispase (STEMCELL Technologies, cat #07923) to obtain single cells or cell clusters ...
-
bioRxiv - Neuroscience 2024Quote: ... and routinely passaged 1:10 every 5 days using Gentle Cell Dissociation Reagent (StemCell Technologies).
-
bioRxiv - Physiology 2024Quote: The iPSCs were cultured on Matrigel-coated plates in mTESR™1 media (STEMCELL Technologies) and passaged manually every 4 to 6 days ...
-
bioRxiv - Neuroscience 2024Quote: Neural progenitor cells (NPCs) derived from XCL-1 iPSCs were obtained from Stem Cell Technologies. NPCs were cultured on matrigel-coated plates (Corning ...
-
bioRxiv - Bioengineering 2024Quote: ... Cells were routinely subcultured at a 1:12 ratio using ReLeSR Passaging Reagent (STEMCELL Technologies) every four days or at 70-80% confluency ...
-
bioRxiv - Microbiology 2022Quote: ... PneumaCult ALI medium supplemented with 4 μg/mL heparin (Stem Cell Technologies), 5 μM hydrocortisone ...
-
bioRxiv - Genomics 2022Quote: ... 4 mL of 29% Iodoxanol cushion was prepared with OptiPrep (Stemcell Technologies) and diluent medium (250 mM sucrose ...
-
Metabolic specialization drives reduced pathogenicity in Pseudomonas aeruginosa CF clinical isolatesbioRxiv - Microbiology 2023Quote: ... 480 ng/mL hydrocortisone and 4 µg/mL heparin (STEMCELL Technologies, 07980). ALI cultures were grown in a 37 °C ...
-
bioRxiv - Neuroscience 2024Quote: ... Embryoid body media (EBM) was used for days 2 to 11 (Supplementary Table 2) and supplemented with 10 µM SB431542 (Stemcell Technologies, #72234), 0.1 µM LDN193189 (MedChemExpress ...
-
bioRxiv - Immunology 2024Quote: ... splenocytes were washed in PBS and resuspended in PBS containing 2%FBS and 2 mM EDTA before negative selection using EasySep Mouse Pan-B Cell Isolation Kit (StemCell Technologies, #19844A) following manufacturer instructions ...
-
bioRxiv - Molecular Biology 2021Quote: ... and human recombinant IL-2 (Stemcell Technologies, Vancouver, Canada). Activated CD4+ T cells were transfected with pVax-CasRx and gRNA plasmids by nucleofection using Lonza 4d nucleofector ...
-
bioRxiv - Bioengineering 2022Quote: ... supplemented with 2 mg/mL heparin (#07980; STEMCELL Technologies) on 10 μg/mL human plasma fibronectin (#FC010 ...
-
bioRxiv - Cancer Biology 2022Quote: ... Fibroblast Growth Factor-2 (FGF2, StemCell Technologies Cat#78134.1), Vascular Endothelial Growth Factor-A (VEGF-165 ...
-
bioRxiv - Cancer Biology 2020Quote: ... supplemented with 2 µg/ml heparin sulfate (STEMCELL Technologies) or SFM supplemented with 20 ng/ml human recombinant epidermal growth factor (hEGF ...
-
bioRxiv - Cancer Biology 2021Quote: ... and heparin sulfate (2 µg/mL; 07980, STEMCELL Technologies). The plates were kept in a 37°C ...
-
bioRxiv - Developmental Biology 2021Quote: ... 2 mg/ml DNase I (Stem Cell Technologies, 07900)) ...
-
bioRxiv - Neuroscience 2024Quote: ... 2% NeuroCult™ SM1 (Stemcell technologies, cat. no. 05711), 1% N-2 Supplement (Thermo Scientific ...
-
bioRxiv - Immunology 2023Quote: ... 2 million CD8 T cells (Stemcell Technologies, Cambridge, MA) from three donors were cultured for 48 hours in AIM V Medium (ThermoFisher Scientific ...
-
bioRxiv - Cancer Biology 2023Quote: ... and 2 μg/ml heparin (#07980, Stem Cell Technologies). All cells were tested for mycoplasma contamination ...
-
bioRxiv - Bioengineering 2023Quote: ... IMDM with 2% FBS (StemCell Technologies, Vancouver, BC, Canada). This HSC:MSC resuspension was added to 1 mL MethoCult H4034 Otimum (StemCell Technologies ...
-
bioRxiv - Cancer Biology 2022Quote: ... heparin (2 μg/ml, Stem Cell Technologies, cat# 7980), human bFGF (10 ng/ml ...
-
bioRxiv - Cancer Biology 2022Quote: ... human recombinant EGF (2 ng/mL, STEMCELL Technologies, #78006.2), antibiotic-antimycotic (1X ...
-
bioRxiv - Immunology 2023Quote: ... An underlay of 2 ml of lymphoprep (STEMCELL technologies) was added ...
-
bioRxiv - Cancer Biology 2024Quote: ... supplemented with 2 μg/mL heparin (Stem Cell Technology), 10 ng/mL FGF (Stem Cell Technology) ...
-
bioRxiv - Immunology 2024Quote: ... 3000 IU/mL recombinant human IL-2 (Stemcell Technologies), and 15 ng/mL recombinant human IL-15 (PeproTech) ...
-
bioRxiv - Cancer Biology 2024Quote: ... Fibroblast Growth Factor-2 (FGF2, StemCell Technologies, Cat#78134.1), and Vascular Endothelial Growth Factor-A (VEGF-165 ...
-
bioRxiv - Neuroscience 2021Quote: ... the iPSC’s were transitioned from Essential 8™ medium to mTeSR™1 medium (StemCell Technologies) for further expansion and analysis ...
-
bioRxiv - Cell Biology 2020Quote: ... BM cells (105) were aliquot in 1 mL of Iscove’s modified Dulbecco’s medium (StemCell Technologies #07700) then 300 µL of this solution was added in 3 mL of MethoCult TM GF3434 (STEMCELL Technologies ...
-
bioRxiv - Neuroscience 2021Quote: ... On day -1 cells were plated into mTeSR1 medium with 0.5 μM Thiazovivin (STEMCELL technologies # 72252) onto hESC-matrigel coated (Corning # 354277 ...
-
bioRxiv - Cancer Biology 2020Quote: ... Cells were adjusted to 1×105 cells/ml final concentration in H4230 methylcellulose medium (STEMCELL Technologies) supplemented with 10% 5637-CM as a stimulant and then plated in 35-mm petri dishes in duplicate and allowed to grow for 7 days in a humidified CO2 incubator (5% CO2 ...
-
bioRxiv - Cancer Biology 2022Quote: ... ES cells were maintained as feeder-free cells in mTeSR™1 medium (Stem Cell Technologies). Cells were allowed to spread overnight prior to transduction ...
-
bioRxiv - Developmental Biology 2021Quote: ... hESC colonies were fragmented and split in a 1:20 ratio following ReLeSR treatment (StemCell Technologies). For directed differentiation experiments ...
-
bioRxiv - Developmental Biology 2020Quote: ... Encapsulated aggregates were allowed to recover for 24 hours in mTeSR™-1 medium (STEMCELL Technologies) in rotary suspension ...
-
bioRxiv - Cell Biology 2020Quote: ... Jurkat cells (Clone E6-1, ATCC® TIB-152(tm)) and PBMCs (Stemcell technologies, Catalog # 70025.1) were cultured at 0.5–1.5 × 10^6 cells/ml in RPMI 1640 media (Corning ...
-
bioRxiv - Cell Biology 2021Quote: ... CD34+ cells (1 × 105/mL) were suspended in serum-free expansion medium II (Stem Cell Technologies) with 50 ng/mL stem cell factor (PeproTech ...
-
bioRxiv - Physiology 2021Quote: ... cell pellets were resuspended in pre-warmed HBSS containing 1 U/ml Dispase (07913, Stemcell Technologies) and 10 µg/ml DNase I (11284932001 ...
-
bioRxiv - Immunology 2021Quote: ... 1000 sorted cells were plated in 1-2ml MethoCultTM GF M3434 (Stemcell Technologies, Catalogue no.-03434) with 50-100 ng/ml M-CSF (PeproTech ...
-
bioRxiv - Immunology 2022Quote: ... Cells were plated at 1 × 106 cells/ml in T cell growth media (StemCell Technology, # 10981) and activated using ImmunoCult™ Human CD3/CD28/CD2 T Cell Activator (StemCell Technology ...
-
bioRxiv - Developmental Biology 2022Quote: H9 hESCs were cultured in mTESR-1 medium supplemented with 10mM ROCKi (Y27632; StemCell Technology 72304) for 24hrs ...
-
bioRxiv - Immunology 2022Quote: ... Biopsies were collected during routine endoscopy and frozen in 1 ml of CryoStor CS10 (StemCell Technologies) at −80 °C ...
-
bioRxiv - Genomics 2024Quote: ... Cells were stimulated with ImmunoCult Human CD3/CD28 T Cell Activator Mix (1:80; StemCell Technology) and incubated at 37°C ...
-
bioRxiv - Bioengineering 2024Quote: ... medium was replaced by RPMI+B27 medium adding 5 μM IWR-1-endo (StemCell Technologies, 72564). At day 4 of the differentiation ...
-
bioRxiv - Developmental Biology 2024Quote: ... iPSCs were cultured on 1:80 diluted geltrex using mTeSR Plus medium (Stem Cell Technologies, Canada) supplemented with 1% Penicillin-streptomycin.
-
bioRxiv - Biophysics 2023Quote: ... with the addition of ImmunoCult Human CD3/CD28/CD2 T Cell Activator and Human Recombinant Interleukin 2 (IL-2, STEMCELL Technologies Inc., USA) as per STEMCELL Technologies Inc ...
-
bioRxiv - Cell Biology 2023Quote: ... with the addition of ImmunoCult Human CD3/CD28/CD2 T Cell Activator and Human Recombinant Interleukin 2 (IL-2, STEMCELL Technologies Inc., USA) as per STEMCELL Technologies Inc ...
-
bioRxiv - Cell Biology 2020Quote: ... at 8.8µg/cm2 and passaged every 4 days using ReLeSR (Stem Cell Technologies). All hPSCs experiments were conducted with cells ranging from 40 and 70 passages ...
-
bioRxiv - Developmental Biology 2021Quote: ... and cells were routinely passaged every 4 days using ReleSR (StemCell Technologies; 05872). CRISPRi-SOX2 cells were plated on vitronectin-coated (ThermoFisher ...
-
bioRxiv - Bioengineering 2021Quote: ... 4 million hiPSC were seeded into an AggreWell 800 well (Stem Cell Technologies) to generate embryoid bodies (EBs ...